Thermo Fisher Scientific Inc (TMO) Scheduled to Post Earnings on Wednesday
Thermo Fisher Scientific Inc (NYSE:TMO) is scheduled to be posting its quarterly earnings results before the market opens on Wednesday, July 26th. Analysts expect Thermo Fisher Scientific to post earnings of $2.26 per share for the quarter. Thermo Fisher Scientific has set its FY17 guidance at $9.12-9.28 EPS.
Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings data on Wednesday, April 26th. The medical research company reported $2.08 EPS for the quarter, topping the Zacks’ consensus estimate of $2.02 by $0.06. Thermo Fisher Scientific had a return on equity of 15.73% and a net margin of 11.58%. The firm had revenue of $4.77 billion for the quarter, compared to the consensus estimate of $4.68 billion. During the same quarter last year, the business posted $1.80 earnings per share. The firm’s revenue was up 10.9% compared to the same quarter last year. On average, analysts expect Thermo Fisher Scientific to post $9.23 EPS for the current fiscal year and $10.18 EPS for the next fiscal year.
Thermo Fisher Scientific Inc (NYSE TMO) opened at 179.35 on Wednesday. The company’s 50-day moving average price is $173.88 and its 200-day moving average price is $158.53. Thermo Fisher Scientific Inc has a 12 month low of $139.07 and a 12 month high of $181.27. The stock has a market cap of $70.17 billion, a P/E ratio of 32.72 and a beta of 1.06.
The company also recently announced a quarterly dividend, which will be paid on Monday, October 16th. Stockholders of record on Friday, September 15th will be issued a $0.15 dividend. This represents a $0.60 annualized dividend and a dividend yield of 0.33%. The ex-dividend date is Thursday, September 14th. Thermo Fisher Scientific’s dividend payout ratio is 10.95%.
In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 20,000 shares of the firm’s stock in a transaction on Thursday, June 1st. The stock was sold at an average price of $172.79, for a total transaction of $3,455,800.00. Following the completion of the transaction, the chief executive officer now owns 269,279 shares of the company’s stock, valued at $46,528,718.41. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Thomas W. Loewald sold 1,532 shares of the firm’s stock in a transaction on Thursday, April 27th. The shares were sold at an average price of $168.76, for a total value of $258,540.32. Following the transaction, the insider now directly owns 41,277 shares of the company’s stock, valued at approximately $6,965,906.52. The disclosure for this sale can be found here. Insiders have sold 28,720 shares of company stock valued at $4,960,764 in the last three months. Insiders own 0.49% of the company’s stock.
TMO has been the subject of a number of research analyst reports. Morgan Stanley raised their price target on Thermo Fisher Scientific from $186.00 to $192.00 and gave the stock an “overweight” rating in a research note on Friday, April 28th. Barclays PLC reaffirmed an “overweight” rating and issued a $190.00 price target (up previously from $175.00) on shares of Thermo Fisher Scientific in a research note on Tuesday, May 9th. Deutsche Bank AG raised their price target on Thermo Fisher Scientific from $163.00 to $188.00 and gave the stock a “buy” rating in a research note on Friday, April 28th. Leerink Swann set a $187.00 price target on Thermo Fisher Scientific and gave the stock a “buy” rating in a research note on Thursday, April 27th. Finally, Cowen and Company reaffirmed an “outperform” rating and issued a $185.00 price target (up previously from $175.00) on shares of Thermo Fisher Scientific in a research note on Saturday, April 29th. Two research analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have assigned a strong buy rating to the stock. Thermo Fisher Scientific has a consensus rating of “Buy” and a consensus target price of $187.29.
Thermo Fisher Scientific Company Profile
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.